Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia

Human Molecular Genetics

Volumn 13, Issue 21, 2004, Pages 2699-2708

  Numakawa, Tadahiro ^a   Yagasaki, Yuki ^a   Ishimoto, Tetsuya ^b   Okada, Takeya ^a   Suzuki, Tatsuyo ^c   Iwata, Nakao ^c   Ozaki, Norio ^d   Taguchi, Takahisa ^b   Tatsumi, Masahiko ^e   Kamijima, Kunitoshi ^e   Straub, Richard E ^f   Weinberger, Daniel R ^f   Kunugi, Hiroshi ^a   Hashimoto, Ryota ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^e SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CHROMOSOME PROTEIN; DYSBINDIN; GLUTAMIC ACID; NUCLEOTIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; POTASSIUM; PROTEIN KINASE B; SMALL INTERFERING RNA; SYNAPSIN I; SYNAPTOSOMAL ASSOCIATED PROTEIN 25; UNCLASSIFIED DRUG;

ARTICLE; BRAIN NERVE CELL; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; EXOCYTOSIS; EXTRACELLULAR SPACE; FEMALE; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; HUMAN CELL; JAPAN; MAJOR CLINICAL STUDY; MALE; NERVE CELL CULTURE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SAMPLING; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; ALLELES; ANIMALS; CARRIER PROTEINS; CELLS, CULTURED; CEREBRAL CORTEX; CHROMONES; CHROMOSOMES, HUMAN, PAIR 6; ENZYME INHIBITORS; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GLUTAMIC ACID; HAPLOTYPES; HUMANS; LINKAGE (GENETICS); LINKAGE DISEQUILIBRIUM; MALE; MEMBRANE PROTEINS; MORPHOLINES; NERVE TISSUE PROTEINS; NEURONS; PHOSPHORYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, INBRED STRAINS; RNA, SMALL INTERFERING; SCHIZOPHRENIA; SYNAPSINS; SYNAPTOSOMAL-ASSOCIATED PROTEIN 25;

EID: 8444250206     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh280     Document Type: Article

References (37)

1. O'Donovan, M.C., Williams, N.M. and Owen, M.J. (2003) Recent advances in the genetics of schizophrenia. Hum. Mol. Genet., 12 R125-R133.
2. Straub, R.E., Jiang, Y., MacLean, C.J., Ma, Y., Webb, B.T., Myakishev, M.V., Harris-Kerr, C., Wormley, B., Sadek, H., Kadambi, B. et al. (2002) Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am. J. Hum. Genet., 71, 337-348.
3. Schwab, S.G., Knapp, M., Mondabon, S., Hallmayer, J., Borrmann-Hassenbach, M., Albus, M., Lerer, B., Rietschel, M., Trixler, M., Maier, W. et al. (2003) Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am. J. Hum. Genet., 72, 185-190.
4. Tang, J.X., Zhou, J., Fan, J.B., Li, X.W., Shi, Y.Y., Gu, N.F., Feng, G.Y., Xing, Y.L., Shi, J.G. and He, L. (2003) Family-based association study of DTNBP1 in 6p22.3 and schizophrenia. Mol. Psychiatr., 8, 717-718.
5. Van Den Bogaert, A., Schumacher, J., Schulze, T.G., Otte, A.C., Ohlraun, S., Kovalenko, S., Becker, T., Freudenberg, J., Jonsson, E.G., Mattila-Evenden, M. et al. (2003) The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am. J. Hum. Genet., 73, 1438-1443.
6. van den Oord, E.J., Sullivan, P.F., Jiang, Y., Walsh, D., O'Neill, F.A., Kendler, K.S. and Riley, B.P. (2003) Identification of a high-risk haplotype for the dystrobrevin binding protein 1 (DTNBP1 gene in the Irish study of high-density schizophrenia families. Mol. Psychiatr., 8, 499-510.
7. Morris, D.W., McGhee, K.A., Schwaiger, S., Scully, P., Quinn, J., Meagher, D., Waddington, J.L., Gill, M. and Corvin, A.P. (2003) No evidence for association of the dysbindin gene [DTNBP1] with schizophrenia in an Irish population-based study. Schizophr. Res., 60, 167-172.
8. Tsai, G. and Coyle, J.T. (2002) Glutamatergic mechanisms in schizophrenia. Annu. Rev. Pharmacol. Toxicol., 42, 165-179.
9. Weinberger, D.R., Egan, M.F., Bertolino, A., Callicott, J.H., Mattay, V.S., Lipska, B.K., Berman, K.F. and Goldberg, T.E. (2001) Prefrontal neurons and the genetics of schizophrenia. Biol. Psychiatr. 50, 825-844.
10. Moghaddam, B. (2003) Bringing order to the glutamate chaos in schizophrenia. Neuron, 40, 881-884.
11. Harrison, P.J. and Owen, M.J. (2003) Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet, 361, 417-419.
12. Buonanno, A. and Fischbach, G.D. (2001) Neuregulin and ErbB receptor signaling pathways in the nervous system. Curr. Opin. Neurobiol., 11, 287-296.
13. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S., Brynjolfsson, J., Gunnarsdottir, S., Ivarsson, O., Chou, T.T. et al. (2002) Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877-892.
14. Mothet, J.P., Parent, A.T., Wolosker, H., Brady, R.O., Jr, Linden, D.J., Ferris, C.D., Rogawski, M.A. and Snyder, S.H. (2000) D-serine is an endogenous ligand for the glycine site of the N methyl-D-aspartate receptor. Proc. Natl Acad. Sci. USA, 97 4926-4931.
15. Chumakov, I., Blumenfeld, M., Guerassimenko, O., Cavarec, L., Palicio, M., Abderrahim, H., Bougueleret, L., Barry, C., Tanaka, H., La Rosa, P. et al. (2002) Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc. Natl Acad. Sci. USA, 99, 13675-13680.
16. De Blasi, A., Conn, P.J., Pin, J. and Nicoletti, F. (2001) Molecular determinants of metabotropic glutamate receptor signaling. Trends Pharmacol. Sci., 22, 114-120.
17. Benson, M.A., Newey, S.E., Martin-Rendon, E., Hawkes, R. and Blake, D.J. (2001) Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J. Biol. Chem. 276, 24232-24241.
18. Turner, K.M., Burgoyne, R.D. and Morgan, A. (1999) Protein phosphorylation and the regulation of synaptic membrane traffic. Trends. Neurosci., 22, 459-464.
19. Brunet, A., Datta, S.R. and Greenberg, M.E. (2001) Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Curr. Opin. Neurobiol., 11, 297-305.
20. Numakawa, T., Nakayama, H., Suzuki, S., Kubo, T., Nara, F., Numakawa, Y., Yokomaku, D., Araki, T., Ishimoto, T., Ogura, A. et al. (2003) Nerve growth factor-induced glutamate release is via p75 receptor, ceramide, and Ca(2+) from ryanodine receptor in developing cerebellar neurons. J. Biol. Chem., 278, 41259-41269.
21. Williams, N.M., Preece, A., Morris, D.W., Spurlock, G., Bray, N.J., Stephens, M., Norton, N., Williams, H., Clement, M., Dwyer, S. et al. (2004) Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1) Arch. Gen. Psychiatr., 61, 336-344.
22. Tokuhiro, S., Yamada, R., Chang, X., Suzuki, A., Kochi, Y., Sawada, T., Suzuki, M., Nagasaki, M., Ohtsuki, M., Ono, M. et al. (2003) An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transport, is associated with rheumatoid arthritis. Nat. Genet., 35, 341-348.
23. McClintock, W., Shannon Weickert, C., Halim, N.D., Lipska, B.K., Hyde, T.M., Herman, M.M., Weinberger, D.R., Kleinman, J.E. and Straub, R.E. (2003) Reduced expression of dysbindin protein in the dorsolateral prefrontal cortex of patients with schizophrenia. Program No. 317.9 2003 Abstract Viewer/Itinerary Planner. Washington, DC, Society for Neuroscience (Online).
24. Talbot, K., Eidem, W.L., Tinsley, C.L., Benson, M.A., Thompson, E.W., Smith, R.J., Hahn, C.G., Siegel, S.J., Trojanowski, J.Q., Gur, R.E. et al. (2004) Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J. Clin. Invest., 113, 1353-1363.
25. Weickert, C.S., Straub, R.E., McClintock, B.W., Matsumoto, M., Hashimoto, R., Hyde, T.M., Herman, M.M., Weinberger, D.R. and Kleinman, J.E. (2004) Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch. Gen. Psychiatr., 61, 544-555.
26. Honer, W.G., Falkai, P., Bayer, T.A., Xie, J., Hu, L., Li, H.Y., Arango, V., Mann, J.J., Dwork, A.J. and Trimble, W.S. (2002) Abnormalities of SNARE mechanism proteins in anterior frontal cortex in severe mental illness. Cereb. Cortex, 12, 349-356.
27. Vawter, M.P., Thatcher, L., Usen, N., Hyde, T.M., Kleinman, J.E. and Freed, W.J. (2002) Reduction of synapsin in the hippocampus of patients with bipolar disorder and schizophrenia. Mol. Psychiatr., 7, 571-578.
28. Emamian, E.S., Hall, D., Birnbaum, M.J., Karayiorgou, M. and Gogos, J.A. (2004) Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat. Genet., 36, 131-137.
29. Li, W., Zhang, Q., Oiso, N., Novak, E.K., Gautam, R., O'Brien, E.P., Tinsley, C.L., Blake, D.J., Spritz, R.A., Copeland, N.G. et al. (2003) Hermansky-Pudlak syndrome type 7 (HPS-7) results from mutant dysbindin, a member of the biogenesis of lysosome-related organelles complex 1 (BLOC-1). Nat. Genet., 35, 84-89.
30. Hashimoto, R., Yoshida, M., Ozaki, N., Yamanouchi, Y., Iwata, N., Suzuki, T., Kitajima, T., Tatsumi, M., Kamijima, K. and Kunugi, H. (2004) Association analysis of the - 308G> A promoter polymorphism of the tumor necrosis factor alpha (TNF-alpha) gene in Japanese patients with schizophrenia. J. Neural Transm., 111, 217-221.
31. Hashimoto, R., Straub, R.E., Weickert, C.S., Hyde, T.M., Kleinman, J.E. and Weinberger, D.R. (2004) Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol. Psychiatr., 9, 299-307.
32. Numakawa, T., Matsumoto, T., Adachi, N., Yokomaku, D., Kojima, M., Takei, N. and Hatanaka, H. (2001) Brain-derived neurotrophic factor triggers a rapid glutamate release through increase of intracellular Ca(2+) and Na(+) in cultured cerebellar neurons. J. Neurosci. Res., 66, 96-108.
33. Numakawa, T., Yamagishi, S., Adachi, N., Matsumoto, T., Yokomaku, D., Yamada, M. and Hatanaka, H. (2002) Brain-derived neurotrophic factor-induced potentiation of Ca(2+) oscillations in developing cortical neurons. J. Biol. Chem., 277, 6520-6529.
34. Kawamura, M., Namba, H., Otsu, Y., Hayashi, Y., Takei, N. and Nawa, H. (2003) Characterization of novel bicistronic sindbis virus vectors, SinEGdsp and SinIRES-EG, in cultured neurons. Recent Res. Dev. Neurochem., 6, 105-120.
35. Numakawa, T., Yokomaku, D., Kiyosue, K., Adachi, N., Matsumoto, T., Numakawa, Y., Taguchi, T., Hatanaka, H. and Yamada, M. (2002) Basic fibroblast growth factor evokes a rapid glutamate release through activation a the MAPK pathway in cultured cortical neurons. J. Biol. Chem., 277, 28861-28869.
36. Hashimoto, R., Nakamura, Y., Komai, S., Kashiwagi, Y., Tamura, K., Goto, T., Aimoto, S., Kaibuchi, K., Shiosaka, S. and Takeda, M. (2000) Site-specific phosphorylation of neurofilament-L is mediated by calcium/calmodulin-dependent protein kinase II in the apical dendrites during long-term potentiation. J. Neurochem., 75, 373-382.
37. Good, P. (2000) Permutation Tests. A Practical Guide to Resampling Methods for Testing Hypothesis. 2nd edn. Springer-Verlag, New York.